Found: 7
Select item for more details and to access through your institution.
Preclinical exploration of combined glucagon inhibition and liver-preferential insulin for treatment of diabetes using in vitro assays and rat and mouse models.
- Published in:
- Diabetologia, 2023, v. 66, n. 2, p. 376, doi. 10.1007/s00125-022-05828-w
- By:
- Publication type:
- Article
Functional significance of brain glycogen in sustaining glutamatergic neurotransmission.
- Published in:
- Journal of Neurochemistry, 2009, v. 109, p. 80, doi. 10.1111/j.1471-4159.2009.05915.x
- By:
- Publication type:
- Article
Characterization of 1,4-dideoxy-1,4-imino-d-arabinitol (DAB) as an inhibitor of brain glycogen shunt activity.
- Published in:
- Journal of Neurochemistry, 2008, v. 105, n. 4, p. 1462, doi. 10.1111/j.1471-4159.2008.05250.x
- By:
- Publication type:
- Article
A Novel Strategy to Prevent Advanced Atherosclerosis and Lower Blood Glucose in a Mouse Model of Metabolic Syndrome.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Treatment of Diabetic Rats With Insulin or a Synthetic Insulin Receptor Agonist Peptide Leads to Divergent Metabolic Responses.
- Published in:
- Diabetes, 2015, v. 64, n. 3, p. 1057, doi. 10.2337/db14-0914
- By:
- Publication type:
- Article
Dual treatment with a fixed ratio of glucagon and insulin increases the therapeutic window of insulin in diabetic rats.
- Published in:
- Physiological Reports, 2018, v. 6, n. 6, p. 1, doi. 10.14814/phy2.13657
- By:
- Publication type:
- Article
Obesity and type 2 diabetes in rats are associated with altered brain glycogen and amino-acid homeostasis.
- Published in:
- Journal of Cerebral Blood Flow & Metabolism, 2010, v. 30, n. 8, p. 1527, doi. 10.1038/jcbfm.2010.61
- By:
- Publication type:
- Article